These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3315585)

  • 61. Study finds similar reperfusion rates with intravenous APSAC and intracoronary streptokinase in acute myocardial infarction.
    Clin Pharm; 1988 Sep; 7(9):634, 638. PubMed ID: 3071445
    [No Abstract]   [Full Text] [Related]  

  • 62. Coronary thrombolysis with intravenous anisoylated plasminogen-streptokinase complex BRL 26921.
    Been M; de Bono DP; Muir AL; Boulton FE; Hillis WS; Hornung R
    Br Heart J; 1985 Mar; 53(3):253-9. PubMed ID: 3882107
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pharmacokinetics, thrombolytic efficacy and hemorrhagic risk of different streptokinase regimens in heparin-treated acute myocardial infarction.
    Col JJ; Col-De Beys CM; Renkin JP; Lavenne-Pardonge EM; Bachy JL; Moriau MH
    Am J Cardiol; 1989 May; 63(17):1185-92. PubMed ID: 2653017
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [New thrombolytic agents in myocardial infarction].
    Charbonnier B; Lang M; Brochier M
    Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Effects of anistreplase on coronary patency in acute myocardial infarction].
    Pacouret G; Charbonnier B
    Arch Mal Coeur Vaiss; 1990 Feb; 83 Spec No 1():25-9. PubMed ID: 2108643
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prehospital administration of anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.
    Castaigne AD; Duval AM; Dubois-Rande JL; Herve C; Jan F; Louvard Y
    Drugs; 1987; 33 Suppl 3():231-4. PubMed ID: 3315600
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prehospital thrombolytic treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex.
    Bossaert LL; Demey HE; Colemont LJ; Beaucourt L; Fierens H; Dirix L; Pintens H
    Crit Care Med; 1988 Sep; 16(9):823-30. PubMed ID: 3042284
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical effects and kinetic properties of intravenous APSAC--anisoylated plasminogen-streptokinase activator complex (BRL 26921) in acute myocardial infarction.
    Been M; de Bono DP; Muir AL; Boulton FE; Fears R; Standring R; Ferres H
    Int J Cardiol; 1986 Apr; 11(1):53-61. PubMed ID: 3514485
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparison of the safety and tolerance of intravenous anisoylated plasminogen streptokinase activator complex and intracoronary streptokinase in acute myocardial infarction.
    de Swart JB
    Drugs; 1987; 33 Suppl 3():279-81. PubMed ID: 3315607
    [No Abstract]   [Full Text] [Related]  

  • 70. The use of BRL26921 (APSAC) as fibrinolytic therapy in acute myocardial infarction.
    Hillis WS; Hornung RS
    Eur Heart J; 1985 Nov; 6(11):909-12. PubMed ID: 3908105
    [No Abstract]   [Full Text] [Related]  

  • 71. Treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex.
    Ikram S; Lewis S; Bucknall C; Sram I; Thomas N; Vincent R; Chamberlain D
    Br Med J (Clin Res Ed); 1986 Sep; 293(6550):786-9. PubMed ID: 3094657
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Accelerated infusion of streptokinase in acute myocardial infarction results in better TIMI flow grade in infarct-related artery.
    Dwivedi SK; Saran RK; Narain VS; Bansal S; Gupta R; Puri VK
    Indian Heart J; 2000; 52(1):40-4. PubMed ID: 10820932
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Effect of thrombolytic agents on infarct size and left ventricle systolic function in myocardial infarction].
    Bassand JP; Cassagnes J; Machecourt J; Anguenot T; Lusson JR; Borel E; Schiele F; Wolf JF; Vachet D
    Arch Mal Coeur Vaiss; 1990 Feb; 83 Spec No 1():31-6. PubMed ID: 2108644
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Fibrinolysis therapy using APSAC in acute myocardial infarct].
    Hochrein H
    Dtsch Med Wochenschr; 1990 Jun; 115(25):999. PubMed ID: 2193790
    [No Abstract]   [Full Text] [Related]  

  • 75. A symposium: Early intervention in the treatment of acute myocardial infarction--clinical profile of Eminase (APSAC). November 12, 1988, Washington, D.C.
    Am J Cardiol; 1989 Jul; 64(2):1A-42A. PubMed ID: 2662736
    [No Abstract]   [Full Text] [Related]  

  • 76. Pharmacology of anistreplase.
    Sherry S
    Clin Cardiol; 1990 Mar; Suppl 5():V3-10; discussion V27-32. PubMed ID: 2182238
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Randomised multicentre trial of anisoylated plasminogen streptokinase activator complex versus heparin. Interim results.
    Meinertz T; Kasper W
    Drugs; 1987; 33 Suppl 3():223-6. PubMed ID: 3315597
    [No Abstract]   [Full Text] [Related]  

  • 78. Angiographic frame counts 90 minutes after streptokinase predict left ventricular function at 48 hours following myocardial infarction.
    French JK; Straznicky IT; Webber BJ; Aylward PE; Frey MJ; Adgey AA; Williams BF; McLaughlin SC; White HD
    Heart; 1999 Feb; 81(2):128-33. PubMed ID: 9922346
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Intracoronary thrombolysis with an acylated streptokinase-plasminogen activator (BRL 26921) in patients with acute myocardial infarction.
    Kasper W; Erbel R; Meinertz T; Drexler M; Rückel A; Pop T; Prellwitz W; Meyer J
    J Am Coll Cardiol; 1984 Aug; 4(2):357-63. PubMed ID: 6429226
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prehospital use of APSAC: results of a placebo-controlled study.
    Castaigne AD; Hervé C; Duval-Moulin AM; Gaillard M; Dubois-Rande JL; Boesch C; Wolf M; Lellouche D; Jan F; Vernant P
    Am J Cardiol; 1989 Jul; 64(2):30A-33A; discussion 41A-42A. PubMed ID: 2662741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.